This report examines the strategic use of procurement to drive innovation within the U.K.’s public health-care system, compares the U.K. experience with Canadian practices and attitudes, and suggests actions to help Canada use this innovation tool.
Innovation Procurement in Health Care: A Compelling Opportunity for Canada
Innovation Procurement in Health Care: A Compelling Opportunity for Canada
$235.00
The sustainability of Canada’s public health-care system will depend in large part on innovations that can enhance the efficiency, safety, quality, and productivity of health and health-care services. Although innovation procurement has been embraced by leading OECD countries, Canada has yet to recognize it as a tool to inject innovation into the health-care system.
This report attempts to contribute to a better understanding of arguments for supporting procurement of innovations by 1) examining current thinking and trends linking procurement with innovation policy; 2) reviewing recent transformations in the United Kingdom’s National Health Service aiming to leverage procurement processes; 3) assessing the perceptions of senior Canadian health-care administrators toward innovation and procurement; and 4) suggesting actions that will help Canada to effectively use this innovation tool to improve health-care system performance and boost Canada’s competitiveness.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
